Save your place

Sign in to WhoBought

Please try again later.

Skye Bioscience, Inc. (SKYE) institutional ownership

Market cap$106M SectorHealthcare
Funds holding · Q3 2023
1
reported SKYE position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q3 2023
Activity unavailable N/A
0 buyers · 1 sellers

Skye Bioscience, Inc. (SKYE) price and institutional activity

Dates

Q3 2023

$0 bought by 0 investors
$0 sold by 1 investors
Mai Capital Management
Bought Sold Totals per quarter; hover a bar for the names.

Skye Bioscience, Inc. (SKYE) institutional activity · 1

Investor Type Est. change Change Δ Own Date
Mai Capital Management · Exited
Change −12K Δ Own −100.0% Date Q3 2023
Mai Capital Management Exited· Q3 2023 −12K −100.0% Q3 2023
Data through Q3 2023 · filed Q3 2023
1 of 1

Skye Bioscience, Inc. (SKYE) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Smith Karen L. · Director Grant (A) 75K
Owned 75K Trade date Mar 31, 2026 Filed date Apr 2, 2026
Smith Karen L. Director Grant (A) 75K 75K Mar 31, 2026 Apr 2, 2026
Twitty Christopher · Officer 6 operations -461K
Owned 0 Trade date Mar 31, 2026 Filed date Apr 2, 2026
Twitty Christopher Officer 6 operations -461K 0 Mar 31, 2026 Apr 2, 2026
Twitty Christopher · Officer 6 operations 461K
Owned 12K Trade date Mar 31, 2026 Filed date Apr 2, 2026
Twitty Christopher Officer 6 operations 461K 12K Mar 31, 2026 Apr 2, 2026
Jenkins Annalisa · Director Grant (A) 75K
Owned 75K Trade date Mar 31, 2026 Filed date Apr 2, 2026
Jenkins Annalisa Director Grant (A) 75K 75K Mar 31, 2026 Apr 2, 2026
Charych Deborah H. · Director Grant (A) 75K
Owned 75K Trade date Mar 31, 2026 Filed date Apr 2, 2026
Charych Deborah H. Director Grant (A) 75K 75K Mar 31, 2026 Apr 2, 2026
Grayson Paul A. · Director Grant (A) 75K
Owned 75K Trade date Mar 31, 2026 Filed date Apr 2, 2026
Grayson Paul A. Director Grant (A) 75K 75K Mar 31, 2026 Apr 2, 2026
Schwab Andrew J. · Director Grant (A) 75K
Owned 75K Trade date Mar 31, 2026 Filed date Apr 2, 2026
Schwab Andrew J. Director Grant (A) 75K 75K Mar 31, 2026 Apr 2, 2026
Diep Tuan Tu · Officer 7 operations -396K
Owned 0 Trade date Mar 31, 2026 Filed date Apr 2, 2026
Diep Tuan Tu Officer 7 operations -396K 0 Mar 31, 2026 Apr 2, 2026
Diep Tuan Tu · Officer 7 operations 396K
Owned 75K Trade date Mar 31, 2026 Filed date Apr 2, 2026
Diep Tuan Tu Officer 7 operations 396K 75K Mar 31, 2026 Apr 2, 2026
Dhillon Punit · Director 7 operations -1.1M
Owned 0 Trade date Mar 31, 2026 Filed date Apr 2, 2026
Dhillon Punit Director 7 operations -1.1M 0 Mar 31, 2026 Apr 2, 2026
Dhillon Punit · Director 7 operations 1.1M
Owned 22K Trade date Mar 31, 2026 Filed date Apr 2, 2026
Dhillon Punit Director 7 operations 1.1M 22K Mar 31, 2026 Apr 2, 2026
Schwab Andrew J. · Director Grant (A) 35K
Owned 35K Trade date Feb 6, 2026 Filed date Feb 9, 2026
Schwab Andrew J. Director Grant (A) 35K 35K Feb 6, 2026 Feb 9, 2026
Grayson Paul A. · Director Grant (A) 35K
Owned 35K Trade date Feb 6, 2026 Filed date Feb 9, 2026
Grayson Paul A. Director Grant (A) 35K 35K Feb 6, 2026 Feb 9, 2026
Smith Karen L. · Director Grant (A) 35K
Owned 35K Trade date Feb 6, 2026 Filed date Feb 9, 2026
Smith Karen L. Director Grant (A) 35K 35K Feb 6, 2026 Feb 9, 2026
Arsenault Kaitlyn · Officer Grant (A) 125K
Owned 125K Trade date Feb 6, 2026 Filed date Feb 9, 2026
Arsenault Kaitlyn Officer Grant (A) 125K 125K Feb 6, 2026 Feb 9, 2026
15 of 25
15 of 25 Sign in to continue to older insider transactions.

Skye Bioscience, Inc. (SKYE) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Schonfeld Strategic Advisors LLC 1.6M
% of shares outstanding 5.2% Filing date May 15, 2025
Schonfeld Strategic Advisors LLC 1.6M 5.2% May 15, 2025
Sphera Funds Management Ltd. 1.5M
% of shares outstanding 4.8% Filing date Apr 10, 2025
Sphera Funds Management Ltd. 1.5M 4.8% Apr 10, 2025
Janus Henderson Group PLC
% of shares outstanding 0.0% Filing date Nov 14, 2024
Janus Henderson Group PLC 0.0% Nov 14, 2024
3 of 3

Skye Bioscience, Inc. (SKYE) ownership FAQ

Who owns SKYE?

1 reporting institutions disclosed SKYE position changes in the Q3 2023 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q3 2023.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.